Our Story
Cancer patients need functional T cells—and so do TCEs. At Encelta, we developed TPRO: an off-the-shelf, safe T cell product that restores anti-tumor immunity and pairs seamlessly with any TCE across indications to meet the needs of patients.
Explore Our Story
TPRO Cells: Engineered for Impact
Our TPRO cells are donor-derived T cells engineered to safely and selectively enhance the activity of T cell engagers without triggering graft-versus-host disease.
Explore Our Science
Useful Links
Explore Our Science
Discover how Encelta is solving one of immunotherapy’s toughest challenges.
Our Story
Encelta started with a discovery and was built on purpose. Here’s how it all came together.
News & Media
Catch up on our latest milestones, media features, publications, and company news.
Contact Us
Let’s talk. Whether it’s partnerships, press, or general inquiries, we’re here.
Recent News
No news at this time
Recent News
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Explore Media Center
Menu
Our universal TPRO cells are engineered with one goal in mind: to enhance the therapeutic activity of T cell engagers (TCEs).
Encelta AG 2025. All Rights Reserved.
